Regulus (RGLS) Stock Skyrockets: Unveiling The Catalysts
The stock value of Regulus Therapeutics Inc. (NASDAQ: RGLS) has increased significantly, rising by 116.67% to $2.99 per share during the current trading session. This remarkable ascent coincides with the publication of encouraging clinical trial results and a calculated equity move. A final shares purchase agreement for a private placement with a limited group of […]
Regulus (RGLS) Stock Skyrockets: Unveiling The Catalysts Read More »